GLG
Get Started
GLG

At-Home Healthcare After COVID-19

With the rapid spread of COVID-19, at-home healthcare became more important than ever. But how were healthcare providers able to pivot to provide adequate care to patients who were already struggling to manage their chronic health conditions? GLG’s Frank Fox spoke with former GLG Social Impact Fellow and CHW Cares Founder Manmeet Kaur to learn […]

TPP Testing in Pharma: Best Practices

Companies regularly test new concepts to stimulate innovation and minimize commercial and financial risk ahead of major business decisions, such as product acquisition, development, and launch. A framed and systematic research methodology showcases concepts with different features and benefits to potential or existing customers. This helps validate a value proposition and estimate its market potential. […]

Drilling into Dental Industry Trends

Over the past few years, the dental industry, like many other industries, has experienced changes that have occurred at an accelerated rate. COVID-19 and its related shutdowns and restrictions had a significant impact on dental practices, but patients are back, and the dentistry industry seems to be exceeding pre-pandemic levels. To discuss this and other […]

Radiation Oncology Market: The Battle for Doctors

To thrive in the competitive radiation oncology marketplace, companies must have referring doctors on their side. It’s the most important element. Even massive, international companies like GenesisCare and Icon rely on individual patients to fuel their revenue streams. Different regions of the world have different characteristics for patient referrals. In a recent teleconference, GLG’s Xavier […]

GLG Institute’s “Effective Leadership Development in a Post-COVID World” roundtable highlights

There are significant disruptions in the world of work. The events and crises during 2020-21 (health, economic, environmental, political, employment, social and racial justice, etc.) magnified previously existing inequities and forced organizations to adapt, transform and reinvent. On November 3, GLG Institute organized a 90-minute roundtable attended by senior HR and business leaders in the […]

Analyzing Australia’s Response to COVID-19

How has Australia responded to the COVID-19 pandemic and the delta variant, and how is it positioned to deal with the pandemic’s evolving challenges? To find out, GLG recently held a remote roundtable with two public health experts: Dr. Stephen Ostroff, a longtime senior official at the U.S. Centers for Disease Control and Prevention and […]

Report: Illuminating Invisible Inequities in Healthcare

Racial disparities in U.S. healthcare garnered more intense scrutiny as COVID-19 impacted minority groups at disproportionately high rates. Growing evidence suggests that implicit bias is among the main factors driving these inequities. Despite an urgent need for systemic change, existing research on implicit bias is mostly academic, and finding clear, actionable guidance on what to do is challenging. GLG Social Impact’s first Insights with Impact report, Illuminating Invisible Inequities in Healthcare, provides a roadmap for organizations seeking […]

Biogen’s Aduhelm: An Update on the Commercial Rollout

The Food and Drug Administration’s (FDA’s) approval of Biogen’s Aduhelm (aducanumab) on June 7, 2021, stirred controversy. Hailed as a breakthrough in treating Alzheimer’s disease, the drug targets the buildup of amyloid beta plaques in the brain, which are thought to be a driver of the disease. Yet there remains a question of whether reducing […]

FDA’s Controversial Aduhelm Approval: What Happens Next?

The FDA caught a lot of flak in June when it approved Biogen’s Aduhelm for the treatment of Alzheimer’s. To learn what happens next for Aduhelm with other government stakeholders, Eric Dimise of GLG’s Healthcare Events team spoke with Michael Adelberg, Principal at Faegre Drinker Consulting, where he leads the Healthcare Strategy practice. Prior to […]

The Future of Healthcare in India

For a glimpse into the future of the healthcare in India, it may help to start with an overview of where we are now. The sector is dominated by India’s biggest hospital groups: Apollo, Fortis, Narayana, Manipal, and Max Healthcare. Apollo Hospitals is largest in terms of revenue and owning, managing, or operating 33 hospitals […]

Report | Illuminating Invisible Inequities in Healthcare: Methods for Measuring and Combatting Implicit Racial Bias

Racial disparities in U.S. healthcare garnered more intense scrutiny as COVID-19 impacted minority groups at disproportionately high rates. Growing evidence suggests that implicit bias is among the main factors driving these inequities. Despite an urgent need for systemic change, existing research on implicit bias is mostly academic, and finding clear, actionable guidance on what to do is challenging. GLG Social Impact’s first Insights with Impact report, Illuminating Invisible Inequities in Healthcare, provides a roadmap for organizations seeking […]

Professor Lawrence Gostin on Mask and Vaccine Mandates

On August 10, GLG hosted a roundtable entitled Vaccine and Mask Mandates: Public Health Response to COVID-19 featuring Lawrence Gostin, O’Neill Professor of Global Health Law and Faculty Director of the O’Neill Institute for National and Global Health Law at Georgetown University. Professor Gostin also directs the WHO Center on National and Global Health Law. […]

Speaker Biographies

Hilary Malone PhD, has over 25 years of experience in global drug development, regulatory &government affairs, manufacturing and commercialization within the biopharma industry. Hilary hassignificant board level and executive committee experience including large scale organizationalrestructuring/transformation/integration, major M&A, biotech start-up, capital raising, investorrelations and pre-IPO.​

Hilary is currently CEO of Stylus Medicine, a private genetic medicine biotech company. Previously sheserved as CEO of a Series-A neuroscience company. Prior to these roles, Hilary served as COO & EVP atValo Health Inc., Chief Regulatory Officer & SVP at Sanofi Inc., and Chief Regulatory Officer & SVP atPfizer and Wyeth. Previous experience also includes senior regulatory and drug development roles atReata Pharmaceuticals Inc., AstraZeneca plc and GlaxoSmithKline plc.​

Hilary also serves on the Board of Directors of Hansa Biopharma and Adthera Bio. Hilary holds a PhD inMolecular Neuropharmacology and a BSc in Physiology.

Dr. Thomas Lönngren is Director at his own company PharmaExec Consulting AB. He is the Chairman of the Board of directors at Egetis Therapeutics AB, Sweden. Dr Lönngren also serves as board member at Compass Pathways PLC, London UK and NDA Group, Sweden. He acts as advisor to the following companies and organizations: NDA group, Sweden, Sweden, Artis Venture, San Francisco, US, Fujimoto Japan, Skin2Neuron Pty Ltd, Sydney, Australia, US, Special advisor to the Centre for Innovation in Regulatory Science (CIRS), London UK. From 2001 until2011, Mr.Lönngren served as the Executive Director of the European Medical Agency. He was previously Deputy General Director of the Swedish Medical Product Agency until 2000. He has a degree in pharmacy and MSc in Social and Regulatory Pharmacy from Uppsala University. He is also an Honorary Member of the Royal Pharmaceutical Society of Great Britain, Honorary Fellow of the Royal College of Physicians in Great Britain, Honorary Doctorate from the University of Uppsala, Honorary Doctorate from University of Bath, UK.

Speaker Biographies

Marie-Anne Aymerich

Marie-Anne has built a portfolio of senior advisory and non-executive roles, following a successful international career in the FMCG and Luxury sectors. She is a non-executive director of Haleon, a FTSE100 company listed in 2022 after the demerger from GSK. She is also chairwoman of Haleon Environment and Societal Sustainability committee. She is the executive director of the Pierre Fabre Group where she also sits on the Strategic Committee, and she is a Board Member of The Academy of St. Martin-in-the-Fields, one of the world’s most prestigious chamber orchestras. She is also an angel investor and focuses her time and investments on start-ups with the strongest purpose and impact.

Marie-Anne is also a regular lecturer at HEC Paris on purposeful leadership, and she has created a serious game called “Planet Purpose” to upskill people on sustainability and purpose. Throughout her 35year executive career she delivered a strong track-record of business performance and growth in brands and portfolio in both developed and emerging economies.

As a senior leader with Unilever, she led a number of different personal care categories across France, Spain and the USA – including managing the Dove brand worldwide and culminating in leading Unilever’s global Oral Care division. She also worked for LVMH as Brand General Manager of Dior Perfumes and Cosmetics worldwide. Marie-Anne was also Vice-President of Imagine for Margo – Children with Cancer for ten years, a charity she helped found in 2011 with the goal of eradicating children’s cancer. The charity is the #1 charity focused on child cancer in France and has fundraised more than €14m since its creation. Marie-Anne is a graduate from HEC Paris. She is married and has two children aged 29 and 26.

Patrick Jephson

Patrick Jephson is a consultant, journalist, broadcaster and New York Times bestselling author, based in Washington D.C. He is a published authority on corporate and personal branding and crisis communications, addressing conferences worldwide as well as events at the U.S. State Department, the American University and the Annenberg School for Communication and Journalism.

With more than twenty-five years’ experience in the government, luxury and family office sectors, Patrick’s portfolio has included globally admired brands as well as national agencies and NGOs. He has also worked on reputation and legacy briefs with European, Middle Eastern and Asian families, including royalty. He now writes, presents, and advises on factual and drama TV programs, appearing on every major American and many international networks. He was recently an expert consultant to the award-winning Netflix series The Crown and provided live commentary on the Coronation of King Charles.

Patrick owes much of his practical communications and protocol experience to Princess Diana, who chose him to be her equerry and only private secretary/chief of staff. He served the Princess for eight years, responsible for all aspects of her public life, global humanitarian initiatives, and private organization. Having worked for an internationally high-profile woman (and as the father of two professionally successful daughters) he feels a special affinity for cross-cultural, gender and perception issues.

Patrick was born and raised in Ireland and holds a master’s degree in political science from Cambridge University. As an officer in the British Royal Navy, he served all over the world before being selected for royal duty. He is a citizen of the U.K., U.S.A., Ireland, and Canada.